02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHOLESTYRAMINE<br />

Trade names: Chol-Less; Colestrol; Lismol; PMS-<br />

Cholestyramine; Prevalite; Quantalan; Questran (Par); Questran<br />

Lite<br />

Indications: Pruritus associated with biliary obstruction, primary<br />

hypercholesterolemia<br />

Category: Bile acid sequestrant<br />

Half-life: N/A<br />

Clinically important, potentially hazardous interactions<br />

with: acetaminophen, acitretin, aspirin, chloroquine, digoxin,<br />

doxepin, fat-soluble vitamins A, D, E, K, hydroxychloroquine,<br />

isotretinoin, lovastatin, mycophenolate, raloxifene, sulfasalazine,<br />

sulfonylureas, tetracycline, tricyclic antidepressants, valproic acid<br />

Reactions<br />

Skin<br />

Edema<br />

Exanthems<br />

Hemorrhage<br />

(1986): Shojania AM+, CMAJ 134(6), 609<br />

Pruritus<br />

(2003): Vroonhof K+, Neth J Med 61(1), 19<br />

Rash (sic) (10%)<br />

(2000): Calista D, J Eur Acad Dermatol Venereol 14(6), 484<br />

Pruritus (1–10%)<br />

Rash (sic) (27%)<br />

(2005): Kuypers DR+, Am J Transplant 5(8), 1997<br />

(2005): Shehab N+, Pharmacotherapy 25(7), 977<br />

Toxicity (sic)<br />

(2003): Ljungman P+, Bone Marrow Transplant 31(6), 481<br />

Urticaria (1–10%)<br />

Xerosis<br />

Mucosal<br />

Aphthous stomatitis<br />

Oral c<strong>and</strong>idiasis<br />

Oral ulceration<br />

Stomatitis (1–10%)<br />

Tongue pigmentation<br />

Xerostomia<br />

Hair<br />

Hair – alopecia (22%)<br />

(2000): Calista D, J Eur Acad Dermatol Venereol 14(6), 484<br />

(transient)<br />

(2000): Seijas M+, Rev Clin Esp 200(10), 584

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!